QQ客服 官方微博 反馈留言

	Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII(+)PTEN(-) glioblastoma in vivo
	Xu, Wen; Bi, Yanyu; Kong, Juan; Zhang, Jiqin; Wang, Biao; Li, Kesang; Tian, Mi; Pan, Xiaorong; Shi, Bizhi; Gu, Jianren
刊名	ONCOTARGET
	2016
卷号	7期号:17
关键词	EGFRvIII(+)PTEN(-) GBM CH12 rapamycin STAT5
ISSN号	1949-2553
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4285900
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Xu, Wen,Bi, Yanyu,Kong, Juan,et al. Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII(+)PTEN(-) glioblastoma in vivo[J]. ONCOTARGET,2016,7(17).
APA	Xu, Wen.,Bi, Yanyu.,Kong, Juan.,Zhang, Jiqin.,Wang, Biao.,...&Li, Zonghai.(2016).Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII(+)PTEN(-) glioblastoma in vivo.ONCOTARGET,7(17).
MLA	Xu, Wen,et al."Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII(+)PTEN(-) glioblastoma in vivo".ONCOTARGET 7.17(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。